Design Therapeutics DSGN
NASDAQ DSGN
$12.50 +0.26 (+2.12%)
As of: Oct 2, 2026 · 10:36 AM EDT

Design Therapeutics (DSGN) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Design Therapeutics (DSGN) recorded Depreciation & Amortization (CF) of $151,000 in Q2 2026, down 0.7% from $152,000 a year earlier and down 3.8% from the prior quarter.

Analysis

Design Therapeutics (DSGN) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

On a TTM basis, Design Therapeutics' Depreciation & Amortization (CF) came in at $619,000 as of Jun 30, 2026, up 1.0% year-over-year; for FY2025, it was $622,000, up 4.4% from FY2024.

  • Annual Depreciation & Amortization (CF) has increased for four straight years, with a five-year compound annual growth rate of 162.4% (FY2020 to FY2025).
  • Across earlier years, Depreciation & Amortization (CF) came in at $596,000 in FY2024 (+11.0%), $537,000 in FY2023 (+32.3%), $406,000 in FY2022 (+214.7%) and $129,000 in FY2021.
  • The Q2 2026 figure is the lowest quarterly Depreciation & Amortization (CF) since Q4 2024.
  • On a year-over-year basis, Depreciation & Amortization (CF) rose in six of the last eight quarters, with growth averaging 4.4%.
  • Peak year-over-year performance for Depreciation & Amortization (CF) in the last five years was growth of 666.7% in Q2 2022, against a decline of 1.3% in Q1 2026 at the low end.
  • Per Business Quant, the preceding three quarters came in at $157,000 (Q1 2026), $156,000 (Q4 2025) and $155,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Design Therapeutics 786.63 Mn -69.40 Mn - 151,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 151,000.00
Mar 31, 2026 157,000.00
Dec 31, 2025 156,000.00
Sep 30, 2025 155,000.00
Jun 30, 2025 152,000.00
Mar 31, 2025 159,000.00
Dec 31, 2024 149,000.00
Sep 30, 2024 153,000.00
Jun 30, 2024 151,000.00
Mar 31, 2024 143,000.00
Dec 31, 2023 138,000.00
Sep 30, 2023 137,000.00
Jun 30, 2023 133,000.00
Mar 31, 2023 129,000.00
Dec 31, 2022 124,000.00
Sep 30, 2022 108,000.00
Jun 30, 2022 92,000.00
Mar 31, 2022 82,000.00
Dec 31, 2021 82,000.00
Sep 30, 2021 31,000.00
API Access

Design Therapeutics Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=DSGN&period=max&api_key=YOUR_API_KEY